Inventor · disambiguated record
Jeremy Travins
Also filed as: TRAVINS JEREMY · TRAVINS JEREMY M · TRAVINS JEREMY MARK
53 granted patents·21 pending applications·358 citations·filing 1997–2023
98Inventor score
Files withAGIOS PHARMACEUTICALS INC34TAKEDA PHARMACEUTICALS CO12SERVIER PHARMACEUTICALS LLC6DIMENSIONAL PHARM INC3JANSSEN PHARMACEUTICA NV3
Top patents by PatentIndex Score
74 records- 0197US9850277B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Dec 26, 2017·22 cites·16 claims
- 0297US9579324B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Feb 28, 2017·22 cites·6 claims
- 0397US9512107B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Dec 6, 2016·25 cites·9 claims
- 0496US10800782B2Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 13, 2020·8 cites·42 claims
- 0596US9656999B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted May 23, 2017·16 cites·4 claims
- 0696US9474779B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Oct 25, 2016·36 cites·18 claims
- 0795US11370803B2Heteroaryl plasma kallikrein inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 28, 2022·5 cites·17 claims
- 0895US10172864B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jan 8, 2019·8 cites·21 claims
- 0994US11787796B2Plasma Kallikrein inhibitors and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Oct 17, 2023·4 cites·20 claims
- 1094US11325914B1Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·2 cites·25 claims
- 1194US9732062B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Aug 15, 2017·18 cites·6 claims
- 1293US11352356B2Inhibitors of plasma kallikrein and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 7, 2022·4 cites·29 claims
- 1393US10329298B2Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Jun 25, 2019·11 cites·32 claims
- 1492US10730874B2Inhibitors of plasma kallikrein and uses thereofSHIRE HUMAN GENETIC THERAPIES·Filed 2019·Granted Aug 4, 2020·7 cites·18 claims
- 1592US8030305B2Triazolopyridazines as kinase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Oct 4, 2011·24 cites·18 claims
- 1690US10294215B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 21, 2019·6 cites·32 claims
- 1790US10028961B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jul 24, 2018·4 cites·9 claims
- 1889US12065448B2Heteroaryl plasma kallikrein inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Aug 20, 2024·1 cites·19 claims
- 1989US9029531B2Compounds and their methods of useLEMIEUX RENE M·Filed 2013·Granted May 12, 2015·8 cites·20 claims
- 2089US8173654B2Triazolopyridazine compoundsLU TIANBAO·Filed 2008·Granted May 8, 2012·21 cites·15 claims
- 2187US11844758B2Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2021·Granted Dec 19, 2023·1 cites·20 claims
- 2287US10717764B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2019·Granted Jul 21, 2020·1 cites·2 claims
- 2387US7138530B2Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditionsDIMENSIONAL PHARM INC·Filed 2003·Granted Nov 21, 2006·29 cites·48 claims
- 2486US11505538B1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Nov 22, 2022·1 cites·8 claims
- 2586US9724350B2N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancerAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Aug 8, 2017·12 cites·14 claims
- 2685US2024059733A1Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 2783US10640534B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 5, 2020·2 cites·6 claims
- 2883US10017495B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Jul 10, 2018·3 cites·17 claims
- 2983US9303002B2Compounds and their methods of useLEMIEUX RENE M·Filed 2013·Granted Apr 5, 2016·6 cites·15 claims
- 3083US7109354B2Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditionsDIMENSIONAL PHARM INC·Filed 2003·Granted Sep 19, 2006·17 cites·16 claims
- 3182US2023250078A1Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 3280US2024199602A1Inhibitors of plasma kallikrein and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 3379US11524960B2Heterobicyclic inhibitors of MAT2A and methods of use for treating cancerAGIOS PHARMACEUTICALS INC·Filed 2019·Granted Dec 13, 2022·2 cites·44 claims
- 3479US11168083B2Inhibitors of Plasma Kallikrein and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 9, 2021·1 cites·20 claims
- 3578US7482376B2Conjugated complement cascade inhibitorsDIMENSIONAL PHARM INC·Filed 2004·Granted Jan 27, 2009·11 cites·11 claims
- 3677US12433895B2Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2023·Granted Oct 7, 2025·0 cites·20 claims
- 3777USRE49934EInhibitors of cellular metabolic processesSERVIER PHARMACEUTICALS LLC·Filed 2022·Granted Apr 23, 2024·0 cites·45 claims
- 3877US10376510B22,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancerAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Aug 13, 2019·3 cites·15 claims
- 3977US9856279B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·1 cites·26 claims
- 4076US10111878B2N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancerAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Oct 30, 2018·2 cites·8 claims
- 4174US11667673B2Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2020·Granted Jun 6, 2023·0 cites·3 claims
- 4273US12221441B2Plasma kallikrein inhibitors and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Feb 11, 2025·0 cites·19 claims
- 4373US11905285B2Inhibitors of plasma kallikrein and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Feb 20, 2024·0 cites·20 claims
- 4472US11021515B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Jun 1, 2021·0 cites·1 claims
- 4572US10011574B2Glutaminase inhibitors and method of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Jul 3, 2018·1 cites·8 claims
- 4671US12441724B2Inhibitors of plasma kallikrein and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Oct 14, 2025·0 cites·29 claims
- 4771US10689414B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Jun 23, 2020·0 cites·1 claims
- 4869US10202339B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Feb 12, 2019·1 cites·11 claims
- 4969US9662327B2Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancerCAO SHELDON·Filed 2012·Granted May 30, 2017·2 cites·22 claims
- 5069US2020079755A1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →